Expertise in
7
conditions

Dr. Robert R. Kohl

Radiation Oncology
Marshfield Medical Center-Dickinson Cancer Center
1721 S Stephenson Ave Ste 100, 
Iron Mountain, MI 
Accepting New Patients
Expertise in
7
conditions
Marshfield Medical Center-Dickinson Cancer Center
1721 S Stephenson Ave Ste 100, 
Iron Mountain, MI 

Overview

Robert Kohl is a Radiation Oncologist practicing medicine in Iron Mountain, Michigan.

Dr. Kohl is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Cholangiocarcinoma (Bile Duct Cancer).

He is actively involved in clinical research, participating in 7 clinical trials. Dr. Kohl is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in WI

Hospital Affiliations

Marshfield Medical Center
Dickinson County Memorial Hospital
Marshfield Medical Center - Minocqua

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Network Health
  • HMO
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Marshfield Medical Center-Dickinson Cancer Center
1721 S Stephenson Ave Ste 100, Iron Mountain, MI 49801

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
Enrollment Status: Completed
Publish Date: July 09, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: June 08, 2026
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
Enrollment Status: Completed
Publish Date: November 03, 2025
Intervention Type: Other
Study Phase: Not Applicable
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Enrollment Status: Unknown
Publish Date: June 12, 2023
Intervention Type: Drug, Radiation
Study Drugs: Cisplatin, Etoposide, Carboplatin
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
0
conditions
Dr. Jason S. Duelge
Radiation Oncology
Expertise in
0
conditions
Dr. Jason S. Duelge
Radiation Oncology
Referral may be required

Dickinson County Healthcare System

1721 S Stephenson Ave, 
Iron Mountain, MI 
 (11.0 miles away)
906-776-5975
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jason Duelge is a Radiation Oncologist practicing medicine in Iron Mountain, Michigan. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Duelge is currently accepting new patients.

Expertise in
0
conditions
Dr. Howard J. Lewis
Radiation Oncology
Expertise in
0
conditions
Dr. Howard J. Lewis
Radiation Oncology
Referral may be required

Dickinson County Healthcare System

1721 S Stephenson Ave, 
Iron Mountain, MI 
 (11.0 miles away)
906-774-1313
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Howard Lewis is a Radiation Oncologist practicing medicine in Iron Mountain, Michigan. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Lewis is currently accepting new patients.

Expertise in
0
conditions
Dr. Eric M. Schaff
Radiation Oncology
Expertise in
0
conditions
Dr. Eric M. Schaff
Radiation Oncology
Referral may be required

Up Health System-Marquette | Cancer Center

850 W Baraga Ave, 
Marquette, MI 
 (48.5 miles away)
906-449-3900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Eric Schaff is a Radiation Oncologist practicing medicine in Marquette, Michigan. His clinical expertise encompasses Mycosis Fungoides and Cutaneous T-Cell Lymphoma (CTCL). Dr. Schaff is currently accepting new patients.

Frequently Asked Questions about Dr. Robert R. Kohl

How do I make an appointment with Dr. Robert R. Kohl?

You can book an appointment with Dr. Robert R. Kohl by calling their office at 906-776-5890. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Robert R. Kohl a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert R. Kohl is classified as an Advanced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Robert R. Kohl specialize in?

While Dr. Robert R. Kohl is a Radiation Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Robert R. Kohl accept my insurance?

Dr. Robert R. Kohl accepts most major insurance plans, including Anthem BCBS and Aspirus Arise Health Plan. We recommend calling the office directly at 906-776-5890 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kohl's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 34 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile